Boston Scientific Faces Class Action Over Q4 Earnings Miss; Stock Drops 17.6%
Law firm Levi & Korsinsky files class action against Boston Scientific, citing misleading statements. Stock tumbled 17.6% after disappointing Q4 2025 earnings and weak 2026 guidance.
BSXALITAQSTsecurities fraudclass action lawsuit
